@article{8391f91e06ac4bb4bf1c798ba58440e6,
title = "Purkinje cell cytoplasmic antibody type i (anti-Yo): Predictive of gastrointestinal adenocarcinomas in men",
keywords = "anti-yo, araneoplastic neurological autoimmunity",
author = "Jenny Linnoila and Yong Guo and Avi Gadoth and Aditya Raghunathan and Becky Parks and Andrew McKeon and Lucchinetti, {Claudia F.} and Lennon, {Vanda A.} and Pittock, {Sean J.}",
note = "Funding Information: Funding SJP has provided consultation to Alexion Pharmaceuticals, Medimmune and Chugai Pharma USA, but has received no personal fees or personal compensation for these consulting activities. All compensation for consulting activities is paid directly to Mayo Clinic. SJP has received research support from Alexion, Medimmune and Grifols. AMcK received research support from and has consulted for euroimmun, Medimmune and Grifols, but has not received personal compensation. CFL has received funding support from Biogen, Novartis, Mallinkrodt and shares in royalties from marketing kits for detecting AQP4 autoantibody. BP has received compensation for consulting from Novartis. BP is currently employed by Biogen.",
year = "2018",
month = oct,
day = "1",
doi = "10.1136/jnnp-2017-316829",
language = "English (US)",
volume = "89",
pages = "1116--1117",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "10",
}